Compounds > 2,3-bis(3'-hydroxybenzyl)butyrolactone
Page last updated: 2024-09-02

2,3-bis(3'-hydroxybenzyl)butyrolactone and homocysteine

2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with homocysteine in 1 studies

Compound Research Comparison

Studies
(2,3-bis(3'-hydroxybenzyl)butyrolactone)		Trials
(2,3-bis(3'-hydroxybenzyl)butyrolactone)		Recent Studies (post-2010)
(2,3-bis(3'-hydroxybenzyl)butyrolactone)		Studies
(homocysteine)		Trials
(homocysteine)		Recent Studies (post-2010) (homocysteine)
3193212415,8711,3485,010

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adlercreutz, H; Kaikkonen, J; Morrow, JD; Nurmi, T; Roberts, LJ; Salonen, JT; Vanharanta, M; Voutilainen, S1

Other Studies

1 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and homocysteine

ArticleYear
Association between low serum enterolactone and increased plasma F2-isoprostanes, a measure of lipid peroxidation.
    Atherosclerosis, 2002, Volume: 160, Issue:2

    Topics: 4-Butyrolactone; Coronary Disease; Estrogens; F2-Isoprostanes; Homocysteine; Humans; Lignans; Lipid Peroxidation; Male; Middle Aged; Multivariate Analysis; Risk Factors

2002